Supernus Pharmaceuticals TCD Royalty Subsidiary's Unit Acquisition

Supernus Pharmaceuticals TCD Royalty Subsidiary raised a round of funding on December 14, 2011. Investors include acquirer.

Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The company is developi…

Articles about Supernus Pharmaceuticals TCD Royalty Subsidiary's Unit Acquisition: